Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
about
Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic IllnessCardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse ModelsDiabetes mellitus and burns. Part I-basic science and implications for managementEffect of Human Burn Wound Exudate on Pseudomonas aeruginosa VirulenceImpact of stress-induced diabetes on outcomes in severely burned childrenAnimal models in burn research.Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial.Computer decision support software safely improves glycemic control in the burn intensive care unit: a randomized controlled clinical study.Changes in fat distribution in children following severe burn injuryInsulin protects against hepatic damage postburn.Beneficial effects of cod protein on inflammatory cell accumulation in rat skeletal muscle after injury are driven by its high levels of arginine, glycine, taurine and lysine.Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns.Protective effect of pretreatment with propofol against tumor necrosis factor-α-induced hepatic insulin resistance.Propranolol improves impaired hepatic phosphatidylinositol 3-kinase/akt signaling after burn injury.Postburn Hypermetabolism: Past, Present, and Future.Signals from fat after injury: plasma adipokines and ghrelin concentrations in the severely burned.Anesthesia with propofol induces insulin resistance systemically in skeletal and cardiac muscles and liver of rats.The relationship between acute and chronic hyperglycemia and outcomes in burn injuryFenofibrate does not affect burn-induced hepatic endoplasmic reticulum stressGlucose control in severely thermally injured pediatric patients: what glucose range should be the target?Nutrition chez le brûlé.Post-burn hepatic insulin resistance is associated with endoplasmic reticulum (ER) stressThe role of hyperglycemia in burned patients: evidence-based studies.Glycemic control in the burn intensive care unit: focus on the role of anemia in glucose measurement.Role of the PPAR-α agonist fenofibrate in severe pediatric burn.Obesity and burns.The impact of prediabetes on glycemic control and clinical outcomes postburn injury.Chronic stress impacts the cardiovascular system: animal models and clinical outcomes.Admission Hyperglycemia Predicts Infectious Complications After Burns.Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 2.The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.Quantity and quality of nocturnal sleep affect morning glucose measurement in acutely burned children.35ème congrès SFB, table ronde «nutrition»: transcription des communications.Previous burn injury predisposes mice to lipopolysaccharide-induced changes in glucose metabolism.Burn injury-induced IRS-1 degradation in mouse skeletal muscle.Stress-Induced Hyperglycemia, but Not Diabetic Hyperglycemia, Is Associated with Higher Mortality in Patients with Isolated Moderate and Severe Traumatic Brain Injury: Analysis of a Propensity Score-Matched Population.Higher Mortality in Trauma Patients Is Associated with Stress-Induced Hyperglycemia, but Not Diabetic Hyperglycemia: A Cross-Sectional Analysis Based on a Propensity-Score Matching Approach.Mechanisms of burn-induced impairment in gastric slow waves and emptying in rats.Beneficial effects of cod protein on skeletal muscle repair following injury.Computerized insulin infusion programs are safe and effective in the burn intensive care unit.
P2860
Q26765501-FDD09C5C-BA88-456C-9541-97516ADD24EFQ26771250-9CB757DA-938F-4868-ADDA-B488DB3762BCQ28084664-62F1FF1F-466A-4978-99BF-C0E5544064EEQ28828916-F92C0A61-D4BE-4A49-988C-C0D8C5588586Q33709684-EF6167EE-30D6-494D-AC31-FA52327AFE6DQ34051592-8EF83775-7653-46E5-9ADB-FDC4D0644B1FQ34065625-56A45781-1150-43BA-B368-5A5AEDE2AFC5Q34590135-FB428A28-8218-476D-8E1E-C8821056D367Q34920165-A1A6C370-581F-410F-BFA8-96C8D4CAFC00Q35017014-C2A4DFC8-D443-4957-8A2D-09157B50FB98Q35017130-2AD33A71-DE72-468A-8F96-7E0359F9702FQ35561653-458FB238-6150-4FC0-A6E1-4D2F6E2E6409Q35803575-9EBB3809-AECA-45BC-8045-766E1F2751D3Q36071747-40FD6FB6-69DC-4F43-9F39-C2D904938868Q36405112-4F68BF59-C7FE-4395-B3E7-12AA08E69E3BQ36420065-A7AA6F6E-8DCB-45B8-9AF0-22695E8DC65AQ36593755-5345A8D1-488A-4BBA-AE4A-1FE890D6A77BQ37259658-C02F3A88-425E-4D68-BA70-A1188F3DEC8CQ37297015-84E61C10-AEBC-4764-BE84-45D37A04E236Q37394359-0C2F29D5-B39E-40B6-8C6B-081E46C9D415Q37412282-5288C036-94BF-41D6-85EF-0525298828D6Q37422501-BB3CF4F6-0E15-4DC1-ACD9-B34196747ED7Q37510565-68659119-98C0-4D1D-BDE2-F232A1CB91ADQ37689882-F145EB89-BAFF-464B-85FB-9CFB6DA536DCQ37973966-92D3ADFB-EE95-46A8-91EE-FFC41644381CQ37978488-0CBA0EEB-E7B0-411A-952E-B93AF27E511CQ38138464-8CED6DE8-4E58-4E59-BE65-9EA66332D62FQ38427411-546E987E-2613-4C99-AECC-247DFEB1D18FQ38880565-914A8D45-36CC-4FDA-9561-D7C515F3B29FQ38935716-A6D5986A-9144-4F90-AF6E-EEDAFC9C78AAQ38986446-D86FE5EE-07A6-456D-B561-5D8ABD07A062Q39363428-2762F4F1-F2F9-4048-A593-0C555BED7243Q41492942-75C30E4B-2458-4BEC-8432-8D8F39C68D33Q41762810-ED026EB9-2DF6-4FF3-A5A9-20F916E3FE3AQ41893791-06E2CBF1-2F96-4463-BD92-439F6E1A271CQ42695172-315962F5-A058-45A8-A1F1-B2FF6351A552Q42696485-E79B269E-D65C-4091-8621-26CFA0A0FD65Q43081564-49F51458-EB3F-4F99-9B70-36120857A592Q45260767-7F56E188-AE00-4A2F-B906-190F64CC3A22Q46280562-E5DA2324-B345-4252-BF9D-CF66A12EABFF
P2860
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
@en
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
@nl
type
label
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
@en
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
@nl
prefLabel
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
@en
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
@nl
P2093
P2860
P1476
Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
@en
P2093
David N Herndon
Gerd G Gauglitz
Marc G Jeschke
P2860
P304
P356
10.1097/BCR.0B013E31818481CE
P577
2008-09-01T00:00:00Z